1Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K,et al. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome[J]. Kidney Int, 2003, 63(2):438-446.
2Proesmans W, Van Dyck M. Enalapril in children with Alport syndrome[J]. Pediatr Nephrol, 2004, 19(3) :271-275.
3Patrakka J, Kestila M, Wartiovaara J, Ruotsalashen V, Tissari P,Lenkkefill, et al. Congenital nephrotic syndrome (NPHS1) : features resulting from different mutations in Finnish patients [ J ].Kidney Int, 2000, 58 (3) :972-980.
4Callis L, Vila A, Carrera M, Nieto J. Long-term effects of cyclosporine A in Alport' s syndrome[J]. Kidney Int, 1999, 55(3) :1051-1056.
5Chen D, Jefferson B, Harvey SJ, Zheng K, Gartleyc J, Jacobs RM, et al. Cyclosporine A slows the progressive renal disease of alport syndrome ( X-linked hereditary nephritis ) : results from a canine model[J]. J Am Soc Nephrol, 2003, 14(3) :690-698.
6Rao VH, Meehan DT, Delimont D, Nakajima M, Wada T, Gratton MA, et al. Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome [ J ].Am J Pathol, 2006, 169( 1 ) :32-46.
7Gross O, Koepke ML, Beirowski B, Schulze-Lohoff E, Segerer S,Weber M. Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688 [J]. Kidney Int,2005, 68(2) :456-463.
8Galadari E, Hadi S, Sabarinathan K. Hartnup disease[J]. Int J Dermatol, 1993, 32(12) :904.
2Hosseini MS, Nemati E, Pourfariziani V, Taheri S, Nourbala MH, Einollahi B, et al. Early hyperglycemia after allogenic kidey trans- plantation: dose it induce infections [ J]. Ann Transplant, 2007, 12(4) : 23-26.
3Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, Kim SH, et al. Risk factors associated with the onset and progression of posttrans- plantation diabetes in renal allograft recipients[ J]. Diabetes Care, 2007, 30(3) : 6094M5.
4Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza Rki, Butler PC, et al. Beta-eell deficit and increased beta-cell apoptosis in humans with type 2 diabetes[J]. Diabetes, 2003, 52( 1 ): 102- 110.
5Yanamadala V, Negoro H, Denker BM. Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes [ J ]. Curt" Mol Med, 2009, 9 ( 5 ) : 527- 545.
